Pandox (OM:PNDX B) Stock Faces One Off Driven Earnings Surge Questioning Bullish Narratives

Pandox (OM:PNDX B) has posted its Q2 2026 numbers with revenue of about SEK 2.2b and net income of SEK 222m, setting the stage for investors to reassess the stock around the current share price of SEK 173.2. The company has seen revenue move from SEK 1.9b in Q2 2025 to SEK 2.2b in Q2 2026, while trailing twelve month revenue sits at SEK 7.9b and net income at SEK 3.2b. This frames a results season where revenue scale and earnings levels are front and center. With that backdrop, the story now turns to how durable these margins look and what the recent earnings profile suggests about the quality of Pandox's underlying operations.

See our full analysis for Pandox.

With the headline figures on the table, the next step is to measure these results against the prevailing Pandox narratives to see which storylines the numbers support and which they challenge.

See what the community is saying about Pandox

Pandox margins shaped by one off gain

• On a trailing basis, Pandox reported net income of about SEK 3.2b on SEK 7.9b of revenue, which translates to a 40.2% net margin compared with 18.8% a year earlier.
• Consensus narrative points to property upgrades and acquisitions as earnings drivers, yet the SEK 1.7b one off gain means:
  • The 135.2% trailing earnings uplift sits well above what recent quarterly net income figures such as SEK 222m in Q2 2026 suggest on their own.
  • Bulls who focus mainly on the stronger trailing margin may underappreciate how much of that profitability is tied to this non recurring item.

Pandox valuation and analyst upside gap

• Pandox trades on a trailing P/E of 10.6x, below peer and industry averages, while the current share price of SEK 173.20 sits below the analyst target of SEK 213.60.
• Supporters of the bullish view highlight revenue growth forecasts of about 4.15% per year, but the data also show:
  • Analysts expect earnings to reach SEK 2.3b by around 2029, which is below the current trailing SEK 3.2b figure, so the price target builds on lower profit but a higher future P/E multiple.
  • The implied upside from SEK 173.20 to SEK 213.60 relies on the market being comfortable with that higher multiple even as margins are expected to narrow from around 48.0% to 25.4%.

On these numbers, bulls see room between today’s 10.6x P/E and the earnings multiple implied by the SEK 213.60 target, while you can compare that gap to other ideas using the screener containing 507 high quality undiscovered gems.

Three year earnings drift worries bears

• Forecasts indicate earnings could decline about 3.3% per year over the next three years even as revenue is expected to grow roughly 4.15% annually.
• Critics focus on the bearish angle that weaker interest coverage and higher loan to value levels limit flexibility, and the figures underline that concern:
  • High loan to value of 47.4% and weak coverage of interest payments mean the current 40.2% trailing margin may not translate into the same level of future cash flow resilience.
  • With earnings expected to fall from about SEK 3.2b to SEK 2.3b over the medium term, bears argue that the recent margin strength and one off gain give a more flattering picture than the forecasts suggest.

Next Steps

To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for Pandox on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.

If this mix of Pandox strengths and concerns feels finely balanced, consider reviewing the numbers yourself promptly and weighing the 5 key rewards and 4 important warning signs.

See What Else Is Out There

Pandox relies significantly on a large one off gain and operates with a high loan to value ratio and weak interest coverage, which raises questions about its balance sheet resilience.

If that combination makes you uneasy, it may be worth comparing Pandox with companies that score better on debt and cash strength using the solid balance sheet and fundamentals stocks screener (416 results).

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com